Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study.
Sandra van BijnenJeska de Vries-BouwstraCornelia H van den EndeMaaike BoonstraLucie KroftBram GeurtsMiranda SnoerenAnne SchouffoerJulia SpieringsJacob M van LaarThomas Wj HuizingaAlexandre VoskuylErik MarijtWalter van der VeldenFrank Hj van den HoogenMadelon C VonkPublished in: Annals of the rheumatic diseases (2020)
Our data confirm long-term efficacy of HSCT in improving survival, skin and lung involvement in SSc. Male sex, lower LVEF and older age at baseline were identified as risk factors for events.